Arabic Arabic English English French French German German
dark

Public Meeting: Patient-Focused Drug Development for Autism (Part 1 of 2)

On May 4, 2017, FDA hosted a public meeting on Patient-Focused Drug Development for Autism. FDA was interested in obtaining patient perspectives on the impact of autism on daily life and patient views on treatment approaches. For more information, visit the meeting webpage: https://go.usa.gov/xAPmG

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Public Meeting: Patient-Focused Drug Development for Autism (Part 2 of 2)

Next Post

MOH Records 147 COVID-19 New Cases, 151 Recoveries in 24 Hours

Related Posts
Total
0
Share